Tyler Kang is an expert in the field of Hematology. He went to Keck School of Medicine of USC. Keck School of Medicine of USC has a rank of 31 in research and a 72 in primary care He has 1 awards "CMS Meaningful Use Stage 1 Certification". Tyler Y. Kang, MD has written publications. He has 3 publications published with PubMed. The lastest publication is: 'Irinotecan and bevacizumab in progressive primary brain tumors, an evaluation of efficacy and safety.' He accepts all Medicare patients.
NPI NUMBER | 1164691820 | |
NPPES Provider LastName | KANG | |
NPPES Provider FirstName | TYLER | |
NPPES Provider ZIPCode | 945782632 | |
NPPES Provider State | CA | |
Specialty Description | Hematology/Oncology | |
Total Claim Count | 816.0 | |
Distinct Opioid Count | 2.0 | |
Opioid Claim Count | 29.0 | |
Percent Opioid Claims | 3.55 |
National Provider Identifier [NPI] | 1164691820 |
Last Name Of The Provider | KANG |
First Name Of The Provider | TYLER |
View All |
![]() |
Dr. John T. Ganey, MD
![]() |
![]() |
Dr. Ravinder K. Arora, MD
![]() |
![]() |
Dr. Jeffrey W. Cronk, MD
![]() |
![]() |
Dr. Amanpreet Buttar, MD
![]() |
![]() |
Dr. Bimal J. Patel, MD
![]() |
![]() |
Dr. Ostap G. Melnyk, MD
![]() |
![]() |
Dr. Shoba Kankipati, MD
![]() |
![]() |
Dr. Gail M. Wagner, MD
![]() |
![]() |
Dr. Srikanth A. Reddy, MD
![]() |